NCT06524531 (Multifidus) is a EARLY_PHASE1 clinical trial of Pulsed RF Neuromodulation in Multi-Organ Disorder, sponsored by Iffat Anwar Medical Complex.

Who is sponsoring NCT06524531?

NCT06524531 is sponsored by Iffat Anwar Medical Complex.

What drugs are being tested in NCT06524531?

Interventions in NCT06524531: Pulsed RF Neuromodulation, Leukocyte-Rich PRP Injection, Physiotherapy Alone.

What condition does NCT06524531 study?

NCT06524531 studies Multi-Organ Disorder.

Is NCT06524531 still recruiting?

NCT06524531 is currently recruiting now. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT06524531: Multifidus

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pulsed RF Neuromodulation and Leukocyte-Rich PRP for Refractory Low Back Pain

Recruiting now EARLY_PHASE1 Last updated 19 September 2024

What this trial tests

EARLY_PHASE1 trial testing Pulsed RF Neuromodulation in Multi-Organ Disorder in 100 participants. Currently enrolling.

Timeline

10 July 2024

Primary endpoint
10 July 2025

30 December 2025

Quick facts

Lead sponsor	Iffat Anwar Medical Complex
Phase	EARLY_PHASE1
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	10 July 2024
Primary completion	10 July 2025
Estimated completion	30 December 2025
Sites	1 location across Pakistan

Drugs / interventions tested

Pulsed RF Neuromodulation
Leukocyte-Rich PRP Injection — full drug profile →
Physiotherapy Alone

Conditions studied

Multi-Organ Disorder — all drugs for Multi-Organ Disorder →

Sponsor

Iffat Anwar Medical Complex — full company profile →

Who can join

Adults 30 to 70, any sex, with Multi-Organ Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial aims to check the safety and efficacy profile of pulsed radiofrequency (RF) neuromodulation combined with leukocyte-rich platelet-rich plasma (PRP) injections for the treatment of refractory low back pain due to multifidus dysfunction. The trial will compare two groups: one receiving standard physical therapy and the other receiving pulsed RF neuromodulation and physiotherapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multi-Organ Disorder

Currently open trials in the same condition.

NCT06221293 — Correlation Between Intra-abdominal Pressure, Biomarkers of Bacterial Translocation and Intestinal Wall Damage · active not recruiting
NCT04510025 — Capturing MultiORgan Effects of COVID-19 · recruiting

Other Iffat Anwar Medical Complex trials

Trials by the same sponsor.

NCT06600529 — Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06524531 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Iffat Anwar Medical Complex
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06524531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing